CN Patent

CN103751186B — 药物制剂：8-[{1-(3,5-双-(三氟甲基)苯基)-乙氧基}-甲基]-8-苯基-1,7-二氮杂-螺[4.5]癸-2-酮的盐及用其治疗的方法

Assigned to Merck Sharp and Dohme LLC · Expires 2016-08-24 · 10y expired

What this patent protects

本发明公开了含有(5S，8S)‑8‑[{(1R)‑1‑(3，5‑双‑三氟甲基)苯基]‑乙氧基}‑甲基]‑8‑苯基‑1，7‑二氮杂螺[4.5]癸‑2‑酮的盐(以式I表示)的药物制剂。也公开了采用此类剂型的治疗方法。

USPTO Abstract

本发明公开了含有(5S，8S)‑8‑[{(1R)‑1‑(3，5‑双‑三氟甲基)苯基]‑乙氧基}‑甲基]‑8‑苯基‑1，7‑二氮杂螺[4.5]癸‑2‑酮的盐(以式I表示)的药物制剂。也公开了采用此类剂型的治疗方法。

Drugs covered by this patent

rolapitant-hydrochloride (ROLAPITANT HYDROCHLORIDE)

Patent Metadata

Patent number: CN103751186B
Jurisdiction: CN
Classification: —
Expires: 2016-08-24
Drug substance claim: No
Drug product claim: No
Assignee: Merck Sharp and Dohme LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.